Search

Your search keyword '"Laclaustra M"' showing total 199 results
Start Over Author "Laclaustra M"
199 results on '"Laclaustra M"'

1. SEA 2022 standards for the comprehensive control of cardiovascular risk

Author

Mostaza, J.M., Pintó, X., Armario, P., Masana, L., Real, J.T., Valdivielso, P., Arrobas-Velilla, T., Baeza-Trinidad, R., Calmarza, P., Cebollada, J., Civera-Andrés, M., Cuende Melero, J.I., Díaz-Díaz, J.L., Fernández Pardo, J., Guijarro, C., Jericó, C., Laclaustra, M., Lahoz, C., López-Miranda, J., Martínez-Hervás, S., Muñiz-Grijalvo, O., Páramo, J.A., Pascual, V., Pedro-Botet, J., Pérez-Martínez, P., Plana, N., Puzo, J., Sánchez Chaparro, M.Á., and Vila, L.

Published
2022
Full Text
View/download PDF

2. Estándares SEA 2022 para el control global del riesgo cardiovascular

Author

Mostaza, Jose Maria, Pintó, Xavier, Armario, Pedro, Masana, Luis, Real, José T., Valdivielso, Pedro, Arrobas-Velilla, Teresa, Baeza-Trinidad, Ramón, Calmarza, Pilar, Cebollada, Jesús, Civera-Andrés, M., Cuende Melero, J.I., Díaz-Díaz, J.L., Fernández Pardo, J., Guijarro, C., Jericó, C., Laclaustra, M., Lahoz, C., López-Miranda, J., Martínez-Hervás, S., Muñiz-Grijalvo, O., Páramo, J.A., Pascual, V., Pedro-Botet, J., Pérez-Martínez, P., Plana, N., Puzo, J., Sánchez Chaparro, M.Á., and Vila, L.

Published
2022
Full Text
View/download PDF

6. The novel Mechanical Ventilator Milano for the COVID-19 pandemic

Author

Abba, A, Accorsi, C, Agnes, P, Alessi, E, Amaudruz, P, Annovi, A, Desages, F, Back, S, Badia, C, Bagger, J, Basile, V, Batignani, G, Bayo, A, Bell, B, Beschi, M, Biagini, D, Bianchi, G, Bicelli, S, Bishop, D, Boccali, T, Bombarda, A, Bonfanti, S, Bonivento, W, Bouchard, M, Breviario, M, Brice, S, Brown, R, Calvo-Mozota, J, Camozzi, L, Camozzi, M, Capra, A, Caravati, M, Carlini, M, Ceccanti, A, Celano, B, Cela Ruiz, J, Charette, C, Cogliati, G, Constable, M, Crippa, C, Croci, G, Cudmore, S, Dahl, C, Dal Molin, A, Daley, M, Di Guardo, C, D'Avenio, G, Davignon, O, Del Tutto, M, De Ruiter, J, Devoto, A, Diaz Gomez Maqueo, P, Di Francesco, F, Dossi, M, Druszkiewicz, E, Duma, C, Elliott, E, Farina, D, Fernandes, C, Ferroni, F, Finocchiaro, G, Fiorillo, G, Ford, R, Foti, G, Fournier, R, Franco, D, Fricbergs, C, Gabriele, F, Galbiati, C, Garcia Abia, P, Gargantini, A, Giacomelli, L, Giacomini, F, Giarratana, L, Gillespie, S, Giorgi, D, Girma, T, Gobui, R, Goeldi, D, Golf, F, Gorel, P, Gorini, G, Gramellini, E, Grosso, G, Guescini, F, Guetre, E, Hackman, G, Hadden, T, Hawkins, W, Hayashi, K, Heavey, A, Hersak, G, Hessey, N, Hockin, G, Hudson, K, Ianni, A, Ienzi, C, Ippolito, V, James, C, Jillings, C, Kendziora, C, Khan, S, Kim, E, King, M, King, S, Kittmer, A, Kochanek, I, Kowalkowski, J, Krucken, R, Kushoro, M, Kuula, S, Laclaustra, M, Leblond, G, Lee, L, Lennarz, A, Leyton, M, Li, X, Liimatainen, P, Lim, C, Lindner, T, Lomonaco, T, Lu, P, Lubna, R, Lukhanin, G, Luzon, G, Macdonald, M, Magni, G, Maharaj, R, Manni, S, Mapelli, C, Margetak, P, Martin, L, Martin, S, Martinez, M, Massacret, N, Mcclurg, P, Mcdonald, A, Meazzi, E, Migalla, R, Mohayai, T, Tosatti, L, Monzani, G, Moretti, C, Morrison, B, Mountaniol, M, Muraro, A, Napoli, P, Nati, F, Natzke, C, Noble, A, Norrick, A, Olchanski, K, Ortiz De Solorzano, A, Padula, F, Pallavicini, M, Palumbo, I, Panontin, E, Papini, N, Parmeggiano, L, Parmeggiano, S, Patel, K, Patel, A, Paterno, M, Pellegrino, C, Pelliccione, P, Pesudo, V, Pocar, A, Pope, A, Pordes, S, Prelz, F, Putignano, O, Raaf, J, Ratti, C, Razeti, M, Razeto, A, Reed, D, Refsgaard, J, Reilly, T, Renshaw, A, Retriere, F, Riccobene, E, Rigamonti, D, Rizzi, A, Rode, J, Romualdez, J, Russel, L, Sablone, D, Sala, S, Salomoni, D, Salvo, P, Sandoval, A, Sansoucy, E, Santorelli, R, Savarese, C, Scapparone, E, Schaubel, T, Scorza, S, Settimo, M, Shaw, B, Shawyer, S, Sher, A, Shi, A, Skensved, P, Slutsky, A, Smith, B, Smith, N, Stenzler, A, Straubel, C, Stringari, P, Suchenek, M, Sur, B, Tacchino, S, Takeuchi, L, Tardocchi, M, Tartaglia, R, Thomas, E, Trask, D, Tseng, J, Tseng, L, Vanpagee, L, Vedia, V, Velghe, B, Viel, S, Visioli, A, Viviani, L, Vonica, D, Wada, M, Walter, D, Wang, H, Wang, M, Westerdale, S, Wood, D, Yates, D, Yue, S, Zambrano, V, Abba A., Accorsi C., Agnes P., Alessi E., Amaudruz P., Annovi A., Desages F. A., Back S., Badia C., Bagger J., Basile V., Batignani G., Bayo A., Bell B., Beschi M., Biagini D., Bianchi G., Bicelli S., Bishop D., Boccali T., Bombarda A., Bonfanti S., Bonivento W. M., Bouchard M., Breviario M., Brice S., Brown R., Calvo-Mozota J. M., Camozzi L., Camozzi M., Capra A., Caravati M., Carlini M., Ceccanti A., Celano B., Cela Ruiz J. M., Charette C., Cogliati G., Constable M., Crippa C., Croci G., Cudmore S., Dahl C. E., Dal Molin A., Daley M., Di Guardo C., D'Avenio G., Davignon O., Del Tutto M., De Ruiter J., Devoto A., Diaz Gomez Maqueo P., Di Francesco F., Dossi M., Druszkiewicz E., Duma C., Elliott E., Farina D., Fernandes C., Ferroni F., Finocchiaro G., Fiorillo G., Ford R., Foti G., Fournier R. D., Franco D., Fricbergs C., Gabriele F., Galbiati C., Garcia Abia P., Gargantini A., Giacomelli L., Giacomini F., Giarratana L. S., Gillespie S., Giorgi D., Girma T., Gobui R., Goeldi D., Golf F., Gorel P., Gorini G., Gramellini E., Grosso G., Guescini F., Guetre E., Hackman G., Hadden T., Hawkins W., Hayashi K., Heavey A., Hersak G., Hessey N., Hockin G., Hudson K., Ianni A., Ienzi C., Ippolito V., James C. C., Jillings C., Kendziora C., Khan S., Kim E., King M., King S., Kittmer A., Kochanek I., Kowalkowski J., Krucken R., Kushoro M., Kuula S., Laclaustra M., Leblond G., Lee L., Lennarz A., Leyton M., Li X., Liimatainen P., Lim C., Lindner T., Lomonaco T., Lu P., Lubna R., Lukhanin G. A., Luzon G., Macdonald M., Magni G., Maharaj R., Manni S., Mapelli C., Margetak P., Martin L., Martin S., Martinez M., Massacret N., McClurg P., McDonald A. B., Meazzi E., Migalla R., Mohayai T., Tosatti L. M., Monzani G., Moretti C., Morrison B., Mountaniol M., Muraro A., Napoli P., Nati F., Natzke C. R., Noble A. J., Norrick A., Olchanski K., Ortiz De Solorzano A., Padula F., Pallavicini M., Palumbo I., Panontin E., Papini N., Parmeggiano L., Parmeggiano S., Patel K., Patel A., Paterno M., Pellegrino C., Pelliccione P., Pesudo V., Pocar A., Pope A., Pordes S., Prelz F., Putignano O., Raaf J. L., Ratti C., Razeti M., Razeto A., Reed D., Refsgaard J., Reilly T., Renshaw A., Retriere F., Riccobene E., Rigamonti D., Rizzi A., Rode J., Romualdez J., Russel L., Sablone D., Sala S., Salomoni D., Salvo P., Sandoval A., Sansoucy E., Santorelli R., Savarese C., Scapparone E., Schaubel T., Scorza S., Settimo M., Shaw B., Shawyer S., Sher A., Shi A., Skensved P., Slutsky A., Smith B., Smith N. J. T., Stenzler A., Straubel C., Stringari P., Suchenek M., Sur B., Tacchino S., Takeuchi L., Tardocchi M., Tartaglia R., Thomas E., Trask D., Tseng J., Tseng L., Vanpagee L., Vedia V., Velghe B., Viel S., Visioli A., Viviani L., Vonica D., Wada M., Walter D., Wang H., Wang M. H. L. S., Westerdale S., Wood D., Yates D., Yue S., Zambrano V., Abba, A, Accorsi, C, Agnes, P, Alessi, E, Amaudruz, P, Annovi, A, Desages, F, Back, S, Badia, C, Bagger, J, Basile, V, Batignani, G, Bayo, A, Bell, B, Beschi, M, Biagini, D, Bianchi, G, Bicelli, S, Bishop, D, Boccali, T, Bombarda, A, Bonfanti, S, Bonivento, W, Bouchard, M, Breviario, M, Brice, S, Brown, R, Calvo-Mozota, J, Camozzi, L, Camozzi, M, Capra, A, Caravati, M, Carlini, M, Ceccanti, A, Celano, B, Cela Ruiz, J, Charette, C, Cogliati, G, Constable, M, Crippa, C, Croci, G, Cudmore, S, Dahl, C, Dal Molin, A, Daley, M, Di Guardo, C, D'Avenio, G, Davignon, O, Del Tutto, M, De Ruiter, J, Devoto, A, Diaz Gomez Maqueo, P, Di Francesco, F, Dossi, M, Druszkiewicz, E, Duma, C, Elliott, E, Farina, D, Fernandes, C, Ferroni, F, Finocchiaro, G, Fiorillo, G, Ford, R, Foti, G, Fournier, R, Franco, D, Fricbergs, C, Gabriele, F, Galbiati, C, Garcia Abia, P, Gargantini, A, Giacomelli, L, Giacomini, F, Giarratana, L, Gillespie, S, Giorgi, D, Girma, T, Gobui, R, Goeldi, D, Golf, F, Gorel, P, Gorini, G, Gramellini, E, Grosso, G, Guescini, F, Guetre, E, Hackman, G, Hadden, T, Hawkins, W, Hayashi, K, Heavey, A, Hersak, G, Hessey, N, Hockin, G, Hudson, K, Ianni, A, Ienzi, C, Ippolito, V, James, C, Jillings, C, Kendziora, C, Khan, S, Kim, E, King, M, King, S, Kittmer, A, Kochanek, I, Kowalkowski, J, Krucken, R, Kushoro, M, Kuula, S, Laclaustra, M, Leblond, G, Lee, L, Lennarz, A, Leyton, M, Li, X, Liimatainen, P, Lim, C, Lindner, T, Lomonaco, T, Lu, P, Lubna, R, Lukhanin, G, Luzon, G, Macdonald, M, Magni, G, Maharaj, R, Manni, S, Mapelli, C, Margetak, P, Martin, L, Martin, S, Martinez, M, Massacret, N, Mcclurg, P, Mcdonald, A, Meazzi, E, Migalla, R, Mohayai, T, Tosatti, L, Monzani, G, Moretti, C, Morrison, B, Mountaniol, M, Muraro, A, Napoli, P, Nati, F, Natzke, C, Noble, A, Norrick, A, Olchanski, K, Ortiz De Solorzano, A, Padula, F, Pallavicini, M, Palumbo, I, Panontin, E, Papini, N, Parmeggiano, L, Parmeggiano, S, Patel, K, Patel, A, Paterno, M, Pellegrino, C, Pelliccione, P, Pesudo, V, Pocar, A, Pope, A, Pordes, S, Prelz, F, Putignano, O, Raaf, J, Ratti, C, Razeti, M, Razeto, A, Reed, D, Refsgaard, J, Reilly, T, Renshaw, A, Retriere, F, Riccobene, E, Rigamonti, D, Rizzi, A, Rode, J, Romualdez, J, Russel, L, Sablone, D, Sala, S, Salomoni, D, Salvo, P, Sandoval, A, Sansoucy, E, Santorelli, R, Savarese, C, Scapparone, E, Schaubel, T, Scorza, S, Settimo, M, Shaw, B, Shawyer, S, Sher, A, Shi, A, Skensved, P, Slutsky, A, Smith, B, Smith, N, Stenzler, A, Straubel, C, Stringari, P, Suchenek, M, Sur, B, Tacchino, S, Takeuchi, L, Tardocchi, M, Tartaglia, R, Thomas, E, Trask, D, Tseng, J, Tseng, L, Vanpagee, L, Vedia, V, Velghe, B, Viel, S, Visioli, A, Viviani, L, Vonica, D, Wada, M, Walter, D, Wang, H, Wang, M, Westerdale, S, Wood, D, Yates, D, Yue, S, Zambrano, V, Abba A., Accorsi C., Agnes P., Alessi E., Amaudruz P., Annovi A., Desages F. A., Back S., Badia C., Bagger J., Basile V., Batignani G., Bayo A., Bell B., Beschi M., Biagini D., Bianchi G., Bicelli S., Bishop D., Boccali T., Bombarda A., Bonfanti S., Bonivento W. M., Bouchard M., Breviario M., Brice S., Brown R., Calvo-Mozota J. M., Camozzi L., Camozzi M., Capra A., Caravati M., Carlini M., Ceccanti A., Celano B., Cela Ruiz J. M., Charette C., Cogliati G., Constable M., Crippa C., Croci G., Cudmore S., Dahl C. E., Dal Molin A., Daley M., Di Guardo C., D'Avenio G., Davignon O., Del Tutto M., De Ruiter J., Devoto A., Diaz Gomez Maqueo P., Di Francesco F., Dossi M., Druszkiewicz E., Duma C., Elliott E., Farina D., Fernandes C., Ferroni F., Finocchiaro G., Fiorillo G., Ford R., Foti G., Fournier R. D., Franco D., Fricbergs C., Gabriele F., Galbiati C., Garcia Abia P., Gargantini A., Giacomelli L., Giacomini F., Giarratana L. S., Gillespie S., Giorgi D., Girma T., Gobui R., Goeldi D., Golf F., Gorel P., Gorini G., Gramellini E., Grosso G., Guescini F., Guetre E., Hackman G., Hadden T., Hawkins W., Hayashi K., Heavey A., Hersak G., Hessey N., Hockin G., Hudson K., Ianni A., Ienzi C., Ippolito V., James C. C., Jillings C., Kendziora C., Khan S., Kim E., King M., King S., Kittmer A., Kochanek I., Kowalkowski J., Krucken R., Kushoro M., Kuula S., Laclaustra M., Leblond G., Lee L., Lennarz A., Leyton M., Li X., Liimatainen P., Lim C., Lindner T., Lomonaco T., Lu P., Lubna R., Lukhanin G. A., Luzon G., Macdonald M., Magni G., Maharaj R., Manni S., Mapelli C., Margetak P., Martin L., Martin S., Martinez M., Massacret N., McClurg P., McDonald A. B., Meazzi E., Migalla R., Mohayai T., Tosatti L. M., Monzani G., Moretti C., Morrison B., Mountaniol M., Muraro A., Napoli P., Nati F., Natzke C. R., Noble A. J., Norrick A., Olchanski K., Ortiz De Solorzano A., Padula F., Pallavicini M., Palumbo I., Panontin E., Papini N., Parmeggiano L., Parmeggiano S., Patel K., Patel A., Paterno M., Pellegrino C., Pelliccione P., Pesudo V., Pocar A., Pope A., Pordes S., Prelz F., Putignano O., Raaf J. L., Ratti C., Razeti M., Razeto A., Reed D., Refsgaard J., Reilly T., Renshaw A., Retriere F., Riccobene E., Rigamonti D., Rizzi A., Rode J., Romualdez J., Russel L., Sablone D., Sala S., Salomoni D., Salvo P., Sandoval A., Sansoucy E., Santorelli R., Savarese C., Scapparone E., Schaubel T., Scorza S., Settimo M., Shaw B., Shawyer S., Sher A., Shi A., Skensved P., Slutsky A., Smith B., Smith N. J. T., Stenzler A., Straubel C., Stringari P., Suchenek M., Sur B., Tacchino S., Takeuchi L., Tardocchi M., Tartaglia R., Thomas E., Trask D., Tseng J., Tseng L., Vanpagee L., Vedia V., Velghe B., Viel S., Visioli A., Viviani L., Vonica D., Wada M., Walter D., Wang H., Wang M. H. L. S., Westerdale S., Wood D., Yates D., Yue S., and Zambrano V.

Abstract

This paper presents the Mechanical Ventilator Milano (MVM), a novel intensive therapy mechanical ventilator designed for rapid, large-scale, low-cost production for the COVID-19 pandemic. Free of moving mechanical parts and requiring only a source of compressed oxygen and medical air to operate, the MVM is designed to support the long-term invasive ventilation often required for COVID-19 patients and operates in pressure-regulated ventilation modes, which minimize the risk of furthering lung trauma. The MVM was extensively tested against ISO standards in the laboratory using a breathing simulator, with good agreement between input and measured breathing parameters and performing correctly in response to fault conditions and stability tests. The MVM has obtained Emergency Use Authorization by U.S. Food and Drug Administration (FDA) for use in healthcare settings during the COVID-19 pandemic and Health Canada Medical Device Authorization for Importation or Sale, under Interim Order for Use in Relation to COVID-19. Following these certifications, mass production is ongoing and distribution is under way in several countries. The MVM was designed, tested, prepared for certification, and mass produced in the space of a few months by a unique collaboration of respiratory healthcare professionals and experimental physicists, working with industrial partners, and is an excellent ventilator candidate for this pandemic anywhere in the world.

Published
2021

7. SEA 2022 Standards for Global Control of Cardiovascular Risk

Author

Universitat Rovira i Virgili, Mostaza JM; Pintó X; Armario P; Masana L; Real JT; Valdivielso P; Arrobas-Velilla T; Baeza-Trinidad R; Calmarza P; Cebollada J; Civera-Andrés M; Cuende Melero JI; Díaz-Díaz JL; Fernández Pardo J; Guijarro C; Jericó C; Laclaustra M; Lahoz C; López-Miranda J; Martínez-Hervás S; Muñiz-Grijalvo O; Páramo JA; Pascual V; Pedro-Botet J; Pérez-Martínez P; Plana N; Puzo J; Sánchez Chaparro M; Vila L, Universitat Rovira i Virgili, and Mostaza JM; Pintó X; Armario P; Masana L; Real JT; Valdivielso P; Arrobas-Velilla T; Baeza-Trinidad R; Calmarza P; Cebollada J; Civera-Andrés M; Cuende Melero JI; Díaz-Díaz JL; Fernández Pardo J; Guijarro C; Jericó C; Laclaustra M; Lahoz C; López-Miranda J; Martínez-Hervás S; Muñiz-Grijalvo O; Páramo JA; Pascual V; Pedro-Botet J; Pérez-Martínez P; Plana N; Puzo J; Sánchez Chaparro M; Vila L

Abstract

One of the objectives of the Spanish Society of Arteriosclerosis is to contribute to better knowledge of vascular disease, its prevention and treatment. It is well known that cardiovascular diseases are the leading cause of death in our country and entail a high degree of disability and health care costs. Arteriosclerosis is a multifactorial disease and therefore its prevention requires a global approach that takes into account the different risk factors with which it is associated. Therefore, this document summarizes the current level of knowledge and includes recommendations and procedures to be followed in patients with established cardiovascular disease or at high vascular risk. Specifically, this document reviews the main symptoms and signs to be evaluated during the clinical visit, the laboratory and imaging procedures to be routinely requested or requested for those in special situations. It also includes vascular risk estimation, the diagnostic criteria of the different entities that are cardiovascular risk factors, and makes general and specific recommendations for the treatment of the different cardiovascular risk factors and their final objectives. Finally, the document includes aspects that are not usually referenced in the literature, such as the organization of a vascular risk consultation.

Published
2022

8. Toxic Metals and Subclinical Atherosclerosis in Carotid, Femoral, and Coronary Vascular Territories: The Aragon Workers Health Study

Author

Grau-Perez M, Caballero-Mateos M, Domingo-Relloso A, Navas-Acien A, Gomez-Ariza J, Garcia-Barrera T, Leon-Latre M, Soriano-Gil Z, Jarauta E, Cenarro A, Moreno-Franco B, Laclaustra M, Civeira F, Casasnovas J, Guallar E, and Tellez-Plaza M

Subjects
inorganic chemicals
Abstract

OBJECTIVE: Studies evaluating the association of metals with subclinical atherosclerosis are mostly limited to carotid arteries. We assessed individual and joint associations of nonessential metals exposure with subclinical atherosclerosis in 3 vascular territories. Approach and Results: One thousand eight hundred seventy-three Aragon Workers Health Study participants had urinary determinations of inorganic arsenic species, barium, cadmium, chromium, antimony, titanium, uranium, vanadium, and tungsten. Plaque presence in carotid and femoral arteries was determined by ultrasound. Coronary Agatston calcium score =1 was determined by computed tomography scan. Median arsenic, barium, cadmium, chromium, antimony, titanium, uranium, vanadium, and tungsten levels were 1.83, 1.98, 0.27, 1.18, 0.05, 9.8, 0.03, 0.66, and 0.23 mug/g creatinine, respectively. The adjusted odds ratio (95% CI) for subclinical atherosclerosis presence in at least one territory was 1.25 (1.03-1.51) for arsenic, 1.67 (1.22-2.29) for cadmium, and 1.26 (1.04-1.52) for titanium. These associations were driven by arsenic and cadmium in carotid, cadmium and titanium in femoral, and titanium in coronary territories and mostly remained after additional adjustment for the other relevant metals. Titanium, cadmium, and antimony also showed positive associations with alternative definitions of increased coronary calcium. Bayesian Kernel Machine Regression analysis simultaneously evaluating metal associations suggested an interaction between arsenic and the joint cadmium-titanium exposure.; CONCLUSIONS: Our results support arsenic and cadmium and identify titanium and potentially antimony as atherosclerosis risk factors. Exposure reduction and mitigation interventions of these metals may decrease cardiovascular risk in individuals without clinical disease.

Published
2022

9. SEA 2022 Standards for Global Control of Cardiovascular Risk

Author

Mostaza, Jose Maria, Pintó, Xavier, Armario, Pedro, Masana, Luis, Real, José T, Valdivielso, Pedro, Arrobas-Velilla, Teresa, Baeza-Trinidad, Ramón, Calmarza, Pilar, Cebollada, Jesús, Civera-Andrés, M, Cuende Melero, J I, Díaz-Díaz, J L, Fernández Pardo, J, Guijarro, C, Jericó, C, Laclaustra, M, Lahoz, C, López-Miranda, J, Martínez-Hervás, S, Muñiz-Grijalvo, O, Páramo, J A, Pascual, V, Pedro-Botet, J, Pérez-Martínez, P, Plana, N, Puzo, J, Sánchez Chaparro, M Á, and Vila, L

Subjects
Arterial hypertension, Dyslipidaemia, Arteriosclerosis, Diabetes, Smoking, Tabaquismo, Fibrilación auricular, Hipertensión arterial, Cardiovascular prevention, Dislipemia, Cardiovascular Diseases, Heart Disease Risk Factors, Risk Factors, Atrial Fibrillation, Prevención cardiovascular, Humans
Abstract

One of the objectives of the Spanish Society of Arteriosclerosis is to contribute to better knowledge of vascular disease, its prevention and treatment. It is well known that cardiovascular diseases are the leading cause of death in our country and entail a high degree of disability and health care costs. Arteriosclerosis is a multifactorial disease and therefore its prevention requires a global approach that takes into account the different risk factors with which it is associated. Therefore, this document summarizes the current level of knowledge and includes recommendations and procedures to be followed in patients with established cardiovascular disease or at high vascular risk. Specifically, this document reviews the main symptoms and signs to be evaluated during the clinical visit, the laboratory and imaging procedures to be routinely requested or requested for those in special situations. It also includes vascular risk estimation, the diagnostic criteria of the different entities that are cardiovascular risk factors, and makes general and specific recommendations for the treatment of the different cardiovascular risk factors and their final objectives. Finally, the document includes aspects that are not usually referenced in the literature, such as the organization of a vascular risk consultation. Copyright © 2021 The Authors. Publicado por Elsevier Espana, S.L.U. All rights reserved.

Published
2021

14. The novel Mechanical Ventilator Milano for the COVID-19 pandemic

Author

Abba, A., primary, Accorsi, C., additional, Agnes, P., additional, Alessi, E., additional, Amaudruz, P., additional, Annovi, A., additional, Desages, F. Ardellier, additional, Back, S., additional, Badia, C., additional, Bagger, J., additional, Basile, V., additional, Batignani, G., additional, Bayo, A., additional, Bell, B., additional, Beschi, M., additional, Biagini, D., additional, Bianchi, G., additional, Bicelli, S., additional, Bishop, D., additional, Boccali, T., additional, Bombarda, A., additional, Bonfanti, S., additional, Bonivento, W. M., additional, Bouchard, M., additional, Breviario, M., additional, Brice, S., additional, Brown, R., additional, Calvo-Mozota, J. M., additional, Camozzi, L., additional, Camozzi, M., additional, Capra, A., additional, Caravati, M., additional, Carlini, M., additional, Ceccanti, A., additional, Celano, B., additional, Cela Ruiz, J. M., additional, Charette, C., additional, Cogliati, G., additional, Constable, M., additional, Crippa, C., additional, Croci, G., additional, Cudmore, S., additional, Dahl, C. E., additional, Dal Molin, A., additional, Daley, M., additional, Di Guardo, C., additional, D'Avenio, G., additional, Davignon, O., additional, Del Tutto, M., additional, De Ruiter, J., additional, Devoto, A., additional, Diaz Gomez Maqueo, P., additional, Di Francesco, F., additional, Dossi, M., additional, Druszkiewicz, E., additional, Duma, C., additional, Elliott, E., additional, Farina, D., additional, Fernandes, C., additional, Ferroni, F., additional, Finocchiaro, G., additional, Fiorillo, G., additional, Ford, R., additional, Foti, G., additional, Fournier, R. D., additional, Franco, D., additional, Fricbergs, C., additional, Gabriele, F., additional, Galbiati, C., additional, Garcia Abia, P., additional, Gargantini, A., additional, Giacomelli, L., additional, Giacomini, F., additional, Giarratana, L. S., additional, Gillespie, S., additional, Giorgi, D., additional, Girma, T., additional, Gobui, R., additional, Goeldi, D., additional, Golf, F., additional, Gorel, P., additional, Gorini, G., additional, Gramellini, E., additional, Grosso, G., additional, Guescini, F., additional, Guetre, E., additional, Hackman, G., additional, Hadden, T., additional, Hawkins, W., additional, Hayashi, K., additional, Heavey, A., additional, Hersak, G., additional, Hessey, N., additional, Hockin, G., additional, Hudson, K., additional, Ianni, A., additional, Ienzi, C., additional, Ippolito, V., additional, James, C. C., additional, Jillings, C., additional, Kendziora, C., additional, Khan, S., additional, Kim, E., additional, King, M., additional, King, S., additional, Kittmer, A., additional, Kochanek, I., additional, Kowalkowski, J., additional, Krücken, R., additional, Kushoro, M., additional, Kuula, S., additional, Laclaustra, M., additional, Leblond, G., additional, Lee, L., additional, Lennarz, A., additional, Leyton, M., additional, Li, X., additional, Liimatainen, P., additional, Lim, C., additional, Lindner, T., additional, Lomonaco, T., additional, Lu, P., additional, Lubna, R., additional, Lukhanin, G. A., additional, Luzón, G., additional, MacDonald, M., additional, Magni, G., additional, Maharaj, R., additional, Manni, S., additional, Mapelli, C., additional, Margetak, P., additional, Martin, L., additional, Martin, S., additional, Martínez, M., additional, Massacret, N., additional, McClurg, P., additional, McDonald, A. B., additional, Meazzi, E., additional, Migalla, R., additional, Mohayai, T., additional, Tosatti, L. M., additional, Monzani, G., additional, Moretti, C., additional, Morrison, B., additional, Mountaniol, M., additional, Muraro, A., additional, Napoli, P., additional, Nati, F., additional, Natzke, C. R., additional, Noble, A. J., additional, Norrick, A., additional, Olchanski, K., additional, Ortiz de Solorzano, A., additional, Padula, F., additional, Pallavicini, M., additional, Palumbo, I., additional, Panontin, E., additional, Papini, N., additional, Parmeggiano, L., additional, Parmeggiano, S., additional, Patel, K., additional, Patel, A., additional, Paterno, M., additional, Pellegrino, C., additional, Pelliccione, P., additional, Pesudo, V., additional, Pocar, A., additional, Pope, A., additional, Pordes, S., additional, Prelz, F., additional, Putignano, O., additional, Raaf, J. L., additional, Ratti, C., additional, Razeti, M., additional, Razeto, A., additional, Reed, D., additional, Refsgaard, J., additional, Reilly, T., additional, Renshaw, A., additional, Retriere, F., additional, Riccobene, E., additional, Rigamonti, D., additional, Rizzi, A., additional, Rode, J., additional, Romualdez, J., additional, Russel, L., additional, Sablone, D., additional, Sala, S., additional, Salomoni, D., additional, Salvo, P., additional, Sandoval, A., additional, Sansoucy, E., additional, Santorelli, R., additional, Savarese, C., additional, Scapparone, E., additional, Schaubel, T., additional, Scorza, S., additional, Settimo, M., additional, Shaw, B., additional, Shawyer, S., additional, Sher, A., additional, Shi, A., additional, Skensved, P., additional, Slutsky, A., additional, Smith, B., additional, Smith, N. J. T., additional, Stenzler, A., additional, Straubel, C., additional, Stringari, P., additional, Suchenek, M., additional, Sur, B., additional, Tacchino, S., additional, Takeuchi, L., additional, Tardocchi, M., additional, Tartaglia, R., additional, Thomas, E., additional, Trask, D., additional, Tseng, J., additional, Tseng, L., additional, VanPagee, L., additional, Vedia, V., additional, Velghe, B., additional, Viel, S., additional, Visioli, A., additional, Viviani, L., additional, Vonica, D., additional, Wada, M., additional, Walter, D., additional, Wang, H., additional, Wang, M. H. L. S., additional, Westerdale, S., additional, Wood, D., additional, Yates, D., additional, Yue, S., additional, and Zambrano, V., additional

Published
2021
Full Text
View/download PDF

15. Risk of cataract surgery in subjects with heterozygous familial hypercholesterolemia in prolonged treatment with statins

Author

Benedí, V. Marco, primary, Laclaustra, M., additional, Casado-Dominguez, J.M., additional, Pobo, R. Villa, additional, Mateo-Gallego, R., additional, Sánchez-Hernández, C.R.M., additional, Nuez, M. Blanco, additional, Ortega-Martínez De Victoria, E., additional, Sitges, M., additional, Pedro-Botet, J., additional, Puzo, J., additional, Villarroel, T., additional, and Civeira, F., additional

Published
2020
Full Text
View/download PDF

17. Effect of lipid-lowering treatment in cardiovascular disease prevalence in familial hypercholesterolemia

Author

Universitat Rovira i Virgili, Perez-Calahorra S, Laclaustra M, Marco-Benedí V, Lamiquiz-Moneo I, Pedro-Botet J, Plana N, Sanchez-Hernandez RM, Amor AJ, Almagro F, Fuentes F, Suarez-Tembra M, Civeira F, Dyslipemia Registry of Spanish Arteriosclerosis Society, Universitat Rovira i Virgili, and Perez-Calahorra S, Laclaustra M, Marco-Benedí V, Lamiquiz-Moneo I, Pedro-Botet J, Plana N, Sanchez-Hernandez RM, Amor AJ, Almagro F, Fuentes F, Suarez-Tembra M, Civeira F, Dyslipemia Registry of Spanish Arteriosclerosis Society

Abstract

The impact on heterozygous familial hypercholesterolemia (HeFH) health led by high-intensity lipid-lowering therapy (HILLT) is unknown, and the question remains if there is still an unacceptably high residual risk to justify treatment with new lipid-lowering drugs.This observational, retrospective, multicenter, national study in Spain, whose information was obtained from a national dyslipemia registry, was designed to establish the current prevalence of cardiovascular disease (CVD) in HeFH and to define the impact of HILLT on CVD in this population. Odds were estimated using several logistic regression models with progressive adjustment.1958 HeFH, mean age 49.3?±?14.3 years, were included in the analysis. At inclusion in the registry, 295 patients (15.1%) had suffered CVD and 164 (55.6%) had suffered the first event before the onset lipid-lowering treatment. Exposition to treatment associated more than ten times lower odds for CVD than in subjects naïve to treatment (OR 0.085, 95% CI 0.063-0.114, p?

Published
2019

30. Selenium Status and Blood Lipids: The Cardiovascular Risk in Young Finns Study

Author

Stranges, S, Tabák, AG, Guallar, E, Rayman, MP, Akbaraly, TN, Laclaustra, M, Alfthan, G, Mussalo-Rauhamaa, H, Viikari, JS, Raitakari, OT, and Kivimäki, M

Subjects
Male, Adolescent, Cholesterol, HDL, Cholesterol, LDL, Article, Selenium, Cross-Sectional Studies, Cardiovascular Diseases, Risk Factors, Child, Preschool, Humans, Female, Child, Finland, Triglycerides, Follow-Up Studies
Abstract

Stranges S, Tabák AG, Guallar E, Rayman MP, Akbaraly TN, Laclaustra M, Alfthan G, Mussalo-Rauhamaa H, Viikari JSA, Raitakari OT, Kivimäki M (Health Sciences Research Institute, University of Warwick Medical School, Coventry; University College London, London, UK; Semmelweis University Faculty of Medicine, Budapest, Hungary; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; National Center for Cardiovascular Research (CNIC), Madrid, Spain; University of Surrey, UK; National Institute of Health and Medical Research (Inserm) U888. F-34000 Montpellier, France; National Institute for Health and Welfare, Helsinki, Finland; Hjelt Institute, University of Helsinki, Helsinki; University of Turku and Turku University Hospital, Turku; University of Turku, Turku; Finnish Institute of Occupational Health and University of Helsinki, Helsinki, Finland). Selenium status and blood lipids: the cardiovascular risk in young finns study. J Intern Med 2011; doi: 10.1111/j.1365-2796.2011.02398.x. Background. Concern has been recently raised about possible adverse cardio-metabolic effects of high selenium status, such as increased risks of diabetes and hyperlipidaemia. However, most of the evidence comes from selenium-replete populations such as that of the United States. Objectives. To examine cross-sectional and longitudinal associations of serum selenium with cardiovascular risk factors in Finland where selenium levels were amongst the lowest in the world until the early 1980s before the implementation of a nationwide selenium fertilization programme. Methods. Serum selenium was measured in 1235 young Finns aged 3-18 years at baseline in 1980 (prefertilization) and in a subgroup (N = 262) at the 6-year follow-up (1986, postfertilization). During the 27-year follow-up, serum lipids, blood pressure, body mass index and smoking were assessed five times (1980, 1983, 1986, 2001 and 2007). Results. Mean (±SD) serum selenium concentrations were 74.3 ± 14.0 ng mL(-1) in 1980 and 106.6 ± 12.5 ng mL(-1) in 1986 (average increase 32.3 ng mL(-1) ; 95% CI: 30.3 to 34.3, P

Published
2011

41. Higher selenium status is associated with adverse blood lipid profile in British adults.

Author

Stranges S, Laclaustra M, Ji C, Cappuccio FP, Navas-Acien A, Ordovas JM, Rayman M, Guallar E, Stranges, Saverio, Laclaustra, Martin, Ji, Chen, Cappuccio, Francesco P, Navas-Acien, Ana, Ordovas, Jose M, Rayman, Margaret, and Guallar, Eliseo

Abstract

Recent findings have raised concern about possible associations of high selenium exposure with diabetes and hyperlipidemia in the US, a population with high selenium status. In the UK, a population with lower selenium status, there is little data on the association of selenium status with cardio-metabolic risk factors in the general population. We examined the association of plasma selenium concentration with blood lipids in a nationally representative sample of British adults. A cross-sectional study was conducted among 1042 white participants (aged 19-64 y) in the 2000-2001 UK National Diet and Nutrition Survey. Plasma selenium was measured by inductively coupled-plasma mass spectrometry. Total and HDL cholesterol were measured in nonfasting plasma samples. Mean plasma selenium concentration was 1.10 +/- 0.19 micromol/L. The multivariate adjusted differences between the highest (> or =1.20 micromol/L) and lowest (<0.98 micromol/L) quartiles of plasma selenium were 0.39 (95% CI 0.18, 0.60) mmol/L for total cholesterol, 0.38 (0.17, 0.59) for non-HDL cholesterol, and 0.01 (-0.05, 0.07) for HDL cholesterol. Higher plasma selenium (i.e., > or =1.20 micromol/L) was associated with increased total and non-HDL cholesterol levels but not with HDL in the UK adult population. These findings raise additional concern about potential adverse cardio-metabolic effects of high selenium status. Randomized and mechanistic evidence is necessary to assess causality and to evaluate the impact of this association on cardiovascular risk. [ABSTRACT FROM AUTHOR]

Published
2010
Full Text
View/download PDF

42. Serum selenium concentrations and diabetes in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004.

Author

Laclaustra M, Navas-Acien A, Stranges S, Ordovas JM, and Guallar E

Abstract

BACKGROUND: Increasing evidence suggests that high selenium levels are associated with diabetes and other cardiometabolic risk factors. OBJECTIVES: We evaluated the association of serum selenium concentrations with fasting plasma glucose, glycosylated hemoglobin levels, and diabetes in the most recently available representative sample of the U.S. population. METHODS: We used a cross-sectional analysis of 917 adults > or = 40 years of age who had a fasting morning blood sample in the National Health and Nutrition Examination Survey 2003-2004. We evaluated the association of serum selenium, measured by inductively coupled plasma-dynamic reaction cell-mass spectrometry, and diabetes, defined as a self-report of current use of hypoglycemic agents or insulin or as fasting plasma glucose > or = 126 mg/dL. RESULTS: Mean serum selenium was 137.1 microg/L. The multivariable adjusted odds ratio [95% confidence interval (CI)] for diabetes comparing the highest quartile of serum selenium (> or = 147 microg/L) with the lowest (< 124 microg/L) was 7.64 (3.34-17.46). The corresponding average differences (95% CI) in fasting plasma glucose and glycosylated hemoglobin were 9.5 mg/dL (3.4-15.6 mg/dL) and 0.30% (0.14-0.46%), respectively. In spline regression models, the prevalence of diabetes as well as glucose and glycosylated hemoglobin levels increased with increasing selenium concentrations up to 160 microg/L. CONCLUSIONS: In U.S. adults, high serum selenium concentrations were associated with higher prevalence of diabetes and higher fasting plasma glucose and glycosylated hemoglobin levels. Given high selenium intake in the U.S. population, further research is needed to determine the role of excess selenium levels in the development or the progression of diabetes. [ABSTRACT FROM AUTHOR]

Published
2009
Full Text
View/download PDF

43. Estándares SEA 2022 para el control global del riesgo cardiovascular

Author

Mostaza, J.M., Pintó, X., Armario, P., Masana, L., Real, J.T., Valdivielso, P., Arrobas-Velilla, T., Baeza-Trinidad, R., Calmarza, P., Cebollada, J., Civera-Andrés, M., Melero, J.I. Cuende, Díaz-Díaz, J.L., Fernández Pardo, J., Guijarro, C., Jericó, C., Laclaustra, M., Lahoz, C., López-Miranda, J., Martínez-Hervás, S., Muñiz-Grijalvo, O., Páramo, J.A., Pascual, V., Pedro-Botet, J., Pérez-Martínez, P., Plana, N., Puzo, J., Sánchez Chaparro, M.Á., and Vila, L.

Abstract

La Sociedad Española de Arteriosclerosis tiene entre sus objetivos contribuir al mayor y mejor conocimiento de la enfermedad vascular, su prevención y su tratamiento. Es de sobra conocido que las enfermedades cardiovasculares son la primera causa de muerte en nuestro país y conllevan además un elevado grado de discapacidad y gasto sanitario. La arteriosclerosis es una enfermedad de causa multifactorial y es por ello que su prevención exige un abordaje global que contemple los distintos factores de riesgo con los que se asocia. Así, este documento resume el nivel actual de conocimientos e incluye recomendaciones y procedimientos a seguir ante el paciente que presenta enfermedad cardiovascular establecida o se encuentra con elevado riesgo vascular. En concreto, este documento revisa los principales síntomas y signos a evaluar durante la visita clínica, los procedimientos de laboratorio y de imagen a solicitar de forma rutinaria o aquellos en situaciones especiales. Igualmente, incluye la estimación del riesgo vascular, los criterios diagnósticos de las distintas entidades que son factores de riesgo cardiovascular, plantea recomendaciones generales y específicas para el tratamiento de los distintos factores de riesgo cardiovascular y sus objetivos finales. Por último, el documento recoge aspectos habitualmente poco referenciados en la literatura como son la organización de una consulta de riesgo vascular.

Published
2021
Full Text
View/download PDF

46. Aragon workers’ health study – design and cohort description

Author

Casasnovas José A, Alcaide Victor, Civeira Fernando, Guallar Eliseo, Ibañez Borja, Borreguero Jesús, Laclaustra Martin, León Montserrat, Peñalvo José, Ordovás José M, Pocovi Miguel, Sanz Ginés, and Fuster Valentín

Subjects
Diseases of the circulatory (Cardiovascular) system, RC666-701
Abstract

Abstract Background Spain, a Mediterranean country with relatively low rates of coronary heart disease, has a high prevalence of traditional cardiovascular risk factors and is experiencing a severe epidemic of overweight/obesity. We designed the Aragon Workers’ Health Study (AWHS) to characterize the factors associated with metabolic abnormalities and subclinical atherosclerosis in a middle aged population in Spain free of clinical cardiovascular disease. The objective of this paper is to describe the study design, aims and baseline characteristics of participants in the AWHS. Methods/Design Longitudinal cohort study based on the annual health exams of 5,400 workers of a car assembly plant in Figueruelas (Zaragoza, Spain). Study participants were recruited during a standardized clinical exam in 2009–2010 (participation rate 95.6%). Study participants will undergo annual clinical exams and laboratory assays, and baseline and triennial collection of biological materials for biobanking and cardiovascular imaging exams (carotid, femoral and abdominal ultrasonography, coronary calcium score, and ankle-arm blood pressure index). Participants will be followed-up for 10 years. Results The average (SD) age, body mass index, and waist circumference were 49.3 (8.7) years, 27.7 (3.6) kg/m2 and 97.2 (9.9) cm, respectively, among males (N = 5,048), and 40.8 (11.6) years, 24.4 (3.8) kg/m2, and 81.9 (9.9) cm, among females (N = 351). The prevalence of overweight, obesity, current smoking, hypertension, hypercholesterolemia, and diabetes were 55.0, 23.1, 37.1, 40.3, 75.0, and 7.4%, respectively, among males, and 23.7, 8.3, 45.0, 12.1, 59.5, and 0.6%, respectively, among females. In the initial 587 study participants who completed all imaging exams (94.5% male), the prevalence of carotid plaque, femoral plaque, coronary calcium score >1 to 100, and coronary calcium score >100 was 30.3, 56.9, 27.0, and 8.8%, respectively. 67.7% of study participants had at least one plaque in the carotid or femoral arteries. Discussion Baseline data from the AWHS show a high prevalence of cardiovascular risk factors and of sublinical atherosclerosis. Follow-up of this cohort will allow the assessment of subclinical atherosclerosis progression and the link of disease progression to traditional and emergent risk factors.

Published
2012
Full Text
View/download PDF

47. A prospective study of dietary selenium intake and risk of type 2 diabetes

Author

Laclaustra Martin, Guallar Eliseo, Vinceti Marco, Grioni Sara, Sieri Sabina, Stranges Saverio, Muti Paola, Berrino Franco, and Krogh Vittorio

Subjects
Public aspects of medicine, RA1-1270
Abstract

Abstract Background Growing evidence raises concern about possible associations of high selenium exposure with diabetes in selenium-replete populations such as the US. In countries with lower selenium status, such as Italy, there is little epidemiological evidence on the association between selenium and diabetes. This study examined the prospective association between dietary selenium intake and risk of type 2 diabetes. Methods The ORDET cohort study comprised a large sample of women from Northern Italy (n = 7,182). Incident type 2 diabetes was defined as a self-report of a physician diagnosis, use of antidiabetic medication, or a hospitalization discharge. Dietary selenium intake was measured by a semi-quantitative food-frequency questionnaire at the baseline examination (1987-1992). Participants were divided in quintiles based on their baseline dietary selenium intake. Results Average selenium intake at baseline was 55.7 μg/day. After a median follow-up of 16 years, 253 women developed diabetes. In multivariate logistic regression analyses, the odds ratio for diabetes comparing the highest to the lowest quintile of selenium intake was 2.39, (95% CI: 1.32, 4.32; P for linear trend = 0.005). The odds ratio for diabetes associated with a 10 μg/d increase in selenium intake was 1.29 (95% CI: 1.10, 1.52). Conclusions In this population, increased dietary selenium intake was associated with an increased risk of type 2 diabetes. These findings raise additional concerns about the association of selenium intake above the Recommended Dietary Allowance (55 μg/day) with diabetes risk.

Published
2010
Full Text
View/download PDF

48. The novel Mechanical Ventilator Milano for the COVID-19 pandemic

Author

M. Tardocchi, P. Lu, Silvia Bonfanti, C. Fricbergs, J. M. Cela Ruiz, M. Del Tutto, R. Brown, D. Salomoni, C. Jillings, A. Visioli, A. Abba, B. Smith, P. Stringari, Valerio Ippolito, K. Olchanski, S. Yue, A. Razeto, L. Parmeggiano, M. Beschi, I. Palumbo, C. C. James, M. Daley, Andrea Bombarda, Eugenio Scapparone, T. Boccali, D. Vonica, G. Luzón, E. Panontin, Nigel Hessey, E. Elliott, O. Putignano, R. Maharaj, M. H. L. S. Wang, M. Laclaustra, A. Sher, E. Gramellini, P. Napoli, S. Parmeggiano, E. Meazzi, S. Sala, A. Muraro, T. Girma, D. Trask, A. Lennarz, F. Golf, G. Magni, C. Di Guardo, A. S. Slutsky, C. Lim, B. Shaw, C. Duma, V. Pesudo, S. Gillespie, A. Devoto, E. Guetre, L. Camozzi, B. Bell, C. E. Dahl, M. Dossi, E. Alessi, M. MacDonald, A. J. Noble, F. Ardellier Desages, O. Davignon, B. Morrison, R. D. Fournier, Alberto Annovi, S. Kuula, Elvinia Riccobene, A. Rizzi, G. Hersak, J. Bagger, S. Brice, S. Khan, L. VanPagee, P. Salvo, R. Lubna, A. Bayo, M. Bouchard, J. Romualdez, G. Bianchi, H. Wang, S. Bicelli, T. A. Mohayai, A. Dal Molin, M. Breviario, C. Ienzi, M. Carlini, K. Hayashi, G. Monzani, G. A. Lukhanin, R. J. Ford, D. Yates, B. Velghe, G. Finocchiaro, C. Charette, M.H. Kushoro, E. Sansoucy, D. Reed, Pierre-Andre Amaudruz, A. Pocar, S. Scorza, M. Camozzi, T. Reilly, C. Crippa, S. Pordes, F. Padula, S. Westerdale, C. Straubel, P. Garcia Abia, A. Shi, D. Giorgi, A. Capra, S. Shawyer, S. Martin, F. Prelz, S. Back, D. Sablone, L. Takeuchi, D. Franco, L. Martin, An. Ianni, L. Tseng, P. McClurg, M. I. Martínez, D. Wood, A. Norrick, C. Pellegrino, J. Tseng, C. Ratti, M. Constable, V. Vedia, L. M. Tosatti, L. S. Giarratana, G. Fiorillo, M. Razeti, A. Patel, C. R. Natzke, S. Manni, M. Wada, S. Tacchino, M. Paterno, P. Gorel, P. Diaz Gomez Maqueo, N. Massacret, S. Cudmore, Marco Pallavicini, A. Heavey, Gabriele Croci, E. Kim, B. Celano, G. Batignani, E. Druszkiewicz, A. L. Renshaw, L. Giacomelli, D. Walter, S. Viel, Angelo Gargantini, D. Goeldi, P. Liimatainen, N. J. T. Smith, T. Schaubel, G. Cogliati, G. Foti, C. Mapelli, F. Retriere, Giuseppe Gorini, K. Patel, R. Tartaglia, N. Papini, M. Settimo, P. Pelliccione, P. Skensved, M. Leyton, V. Basile, A. Kittmer, G. D'Avenio, D. Rigamonti, R. Krücken, F. Guescini, F. Giacomini, E. Thomas, K. Hudson, Claudio Moretti, R. Santorelli, G. Hackman, R. Gobui, L. Viviani, C. Savarese, I. Kochanek, R. Migalla, J. Rode, F. Gabriele, D. Farina, F. Ferroni, F. Di Francesco, J. M. Calvo-Mozota, M. Suchenek, G. Hockin, J. Refsgaard, J. Kowalkowski, A. Pope, T. Lomonaco, S. King, Bhaskar Sur, C. L. Kendziora, M. Caravati, A. Ceccanti, W. Hawkins, W. Bonivento, C. Fernandes, G. Leblond, M. Mountaniol, A. B. McDonald, C. Accorsi, A. Stenzler, Federico Nati, V. Zambrano, D. Bishop, M. King, A. Sandoval, X. Li, P. Margetak, P. Agnes, J. L. Raaf, J. De Ruiter, Cristiano Galbiati, Giovanni Grosso, L. Lee, A. Ortiz de Solórzano, T. Hadden, T. Lindner, D. Biagini, L. Russel, C. Badia, Abba, A., Accorsi, C., Agnes, P., Alessi, E., Amaudruz, P., Annovi, A., Desages, F. A., Back, S., Badia, C., Bagger, J., Basile, V., Batignani, G., Bayo, A., Bell, B., Beschi, M., Biagini, D., Bianchi, G., Bicelli, S., Bishop, D., Boccali, T., Bombarda, A., Bonfanti, S., Bonivento, W. M., Bouchard, M., Breviario, M., Brice, S., Brown, R., Calvo-Mozota, J. M., Camozzi, L., Camozzi, M., Capra, A., Caravati, M., Carlini, M., Ceccanti, A., Celano, B., Cela Ruiz, J. M., Charette, C., Cogliati, G., Constable, M., Crippa, C., Croci, G., Cudmore, S., Dahl, C. E., Dal Molin, A., Daley, M., Di Guardo, C., D'Avenio, G., Davignon, O., Del Tutto, M., De Ruiter, J., Devoto, A., Diaz Gomez Maqueo, P., Di Francesco, F., Dossi, M., Druszkiewicz, E., Duma, C., Elliott, E., Farina, D., Fernandes, C., Ferroni, F., Finocchiaro, G., Fiorillo, G., Ford, R., Foti, G., Fournier, R. D., Franco, D., Fricbergs, C., Gabriele, F., Galbiati, C., Garcia Abia, P., Gargantini, A., Giacomelli, L., Giacomini, F., Giarratana, L. S., Gillespie, S., Giorgi, D., Girma, T., Gobui, R., Goeldi, D., Golf, F., Gorel, P., Gorini, G., Gramellini, E., Grosso, G., Guescini, F., Guetre, E., Hackman, G., Hadden, T., Hawkins, W., Hayashi, K., Heavey, A., Hersak, G., Hessey, N., Hockin, G., Hudson, K., Ianni, A., Ienzi, C., Ippolito, V., James, C. C., Jillings, C., Kendziora, C., Khan, S., Kim, E., King, M., King, S., Kittmer, A., Kochanek, I., Kowalkowski, J., Krucken, R., Kushoro, M., Kuula, S., Laclaustra, M., Leblond, G., Lee, L., Lennarz, A., Leyton, M., Li, X., Liimatainen, P., Lim, C., Lindner, T., Lomonaco, T., Lu, P., Lubna, R., Lukhanin, G. A., Luzon, G., Macdonald, M., Magni, G., Maharaj, R., Manni, S., Mapelli, C., Margetak, P., Martin, L., Martin, S., Martinez, M., Massacret, N., Mcclurg, P., Mcdonald, A. B., Meazzi, E., Migalla, R., Mohayai, T., Tosatti, L. M., Monzani, G., Moretti, C., Morrison, B., Mountaniol, M., Muraro, A., Napoli, P., Nati, F., Natzke, C. R., Noble, A. J., Norrick, A., Olchanski, K., Ortiz De Solorzano, A., Padula, F., Pallavicini, M., Palumbo, I., Panontin, E., Papini, N., Parmeggiano, L., Parmeggiano, S., Patel, K., Patel, A., Paterno, M., Pellegrino, C., Pelliccione, P., Pesudo, V., Pocar, A., Pope, A., Pordes, S., Prelz, F., Putignano, O., Raaf, J. L., Ratti, C., Razeti, M., Razeto, A., Reed, D., Refsgaard, J., Reilly, T., Renshaw, A., Retriere, F., Riccobene, E., Rigamonti, D., Rizzi, A., Rode, J., Romualdez, J., Russel, L., Sablone, D., Sala, S., Salomoni, D., Salvo, P., Sandoval, A., Sansoucy, E., Santorelli, R., Savarese, C., Scapparone, E., Schaubel, T., Scorza, S., Settimo, M., Shaw, B., Shawyer, S., Sher, A., Shi, A., Skensved, P., Slutsky, A., Smith, B., Smith, N. J. T., Stenzler, A., Straubel, C., Stringari, P., Suchenek, M., Sur, B., Tacchino, S., Takeuchi, L., Tardocchi, M., Tartaglia, R., Thomas, E., Trask, D., Tseng, J., Tseng, L., Vanpagee, L., Vedia, V., Velghe, B., Viel, S., Visioli, A., Viviani, L., Vonica, D., Wada, M., Walter, D., Wang, H., Wang, M. H. L. S., Westerdale, S., Wood, D., Yates, D., Yue, S., Zambrano, V., AstroParticule et Cosmologie (APC (UMR_7164)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Observatoire de Paris, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP), Laboratoire Leprince-Ringuet (LLR), Centre National de la Recherche Scientifique (CNRS)-École polytechnique (X)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3), Laboratoire de Physique Nucléaire et de Hautes Énergies (LPNHE (UMR_7585)), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP), Laboratoire de physique subatomique et des technologies associées (SUBATECH), Université de Nantes - UFR des Sciences et des Techniques (UN UFR ST), Université de Nantes (UN)-Université de Nantes (UN)-Centre National de la Recherche Scientifique (CNRS)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-IMT Atlantique Bretagne-Pays de la Loire (IMT Atlantique), Institut Mines-Télécom [Paris] (IMT)-Institut Mines-Télécom [Paris] (IMT), École des Mines de Paris, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-École polytechnique (X)-Centre National de la Recherche Scientifique (CNRS), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Université de Nantes (UN)-Université de Nantes (UN)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS)-IMT Atlantique (IMT Atlantique), Abba, A, Accorsi, C, Agnes, P, Alessi, E, Amaudruz, P, Annovi, A, Desages, F, Back, S, Badia, C, Bagger, J, Basile, V, Batignani, G, Bayo, A, Bell, B, Beschi, M, Biagini, D, Bianchi, G, Bicelli, S, Bishop, D, Boccali, T, Bombarda, A, Bonfanti, S, Bonivento, W, Bouchard, M, Breviario, M, Brice, S, Brown, R, Calvo-Mozota, J, Camozzi, L, Camozzi, M, Capra, A, Caravati, M, Carlini, M, Ceccanti, A, Celano, B, Cela Ruiz, J, Charette, C, Cogliati, G, Constable, M, Crippa, C, Croci, G, Cudmore, S, Dahl, C, Dal Molin, A, Daley, M, Di Guardo, C, D'Avenio, G, Davignon, O, Del Tutto, M, De Ruiter, J, Devoto, A, Diaz Gomez Maqueo, P, Di Francesco, F, Dossi, M, Druszkiewicz, E, Duma, C, Elliott, E, Farina, D, Fernandes, C, Ferroni, F, Finocchiaro, G, Fiorillo, G, Ford, R, Foti, G, Fournier, R, Franco, D, Fricbergs, C, Gabriele, F, Galbiati, C, Garcia Abia, P, Gargantini, A, Giacomelli, L, Giacomini, F, Giarratana, L, Gillespie, S, Giorgi, D, Girma, T, Gobui, R, Goeldi, D, Golf, F, Gorel, P, Gorini, G, Gramellini, E, Grosso, G, Guescini, F, Guetre, E, Hackman, G, Hadden, T, Hawkins, W, Hayashi, K, Heavey, A, Hersak, G, Hessey, N, Hockin, G, Hudson, K, Ianni, A, Ienzi, C, Ippolito, V, James, C, Jillings, C, Kendziora, C, Khan, S, Kim, E, King, M, King, S, Kittmer, A, Kochanek, I, Kowalkowski, J, Krucken, R, Kushoro, M, Kuula, S, Laclaustra, M, Leblond, G, Lee, L, Lennarz, A, Leyton, M, Li, X, Liimatainen, P, Lim, C, Lindner, T, Lomonaco, T, Lu, P, Lubna, R, Lukhanin, G, Luzon, G, Macdonald, M, Magni, G, Maharaj, R, Manni, S, Mapelli, C, Margetak, P, Martin, L, Martin, S, Martinez, M, Massacret, N, Mcclurg, P, Mcdonald, A, Meazzi, E, Migalla, R, Mohayai, T, Tosatti, L, Monzani, G, Moretti, C, Morrison, B, Mountaniol, M, Muraro, A, Napoli, P, Nati, F, Natzke, C, Noble, A, Norrick, A, Olchanski, K, Ortiz De Solorzano, A, Padula, F, Pallavicini, M, Palumbo, I, Panontin, E, Papini, N, Parmeggiano, L, Parmeggiano, S, Patel, K, Patel, A, Paterno, M, Pellegrino, C, Pelliccione, P, Pesudo, V, Pocar, A, Pope, A, Pordes, S, Prelz, F, Putignano, O, Raaf, J, Ratti, C, Razeti, M, Razeto, A, Reed, D, Refsgaard, J, Reilly, T, Renshaw, A, Retriere, F, Riccobene, E, Rigamonti, D, Rizzi, A, Rode, J, Romualdez, J, Russel, L, Sablone, D, Sala, S, Salomoni, D, Salvo, P, Sandoval, A, Sansoucy, E, Santorelli, R, Savarese, C, Scapparone, E, Schaubel, T, Scorza, S, Settimo, M, Shaw, B, Shawyer, S, Sher, A, Shi, A, Skensved, P, Slutsky, A, Smith, B, Smith, N, Stenzler, A, Straubel, C, Stringari, P, Suchenek, M, Sur, B, Tacchino, S, Takeuchi, L, Tardocchi, M, Tartaglia, R, Thomas, E, Trask, D, Tseng, J, Tseng, L, Vanpagee, L, Vedia, V, Velghe, B, Viel, S, Visioli, A, Viviani, L, Vonica, D, Wada, M, Walter, D, Wang, H, Wang, M, Westerdale, S, Wood, D, Yates, D, Yue, S, and Zambrano, V

Subjects
ventilator, Emergency Use Authorization, Coronavirus disease 2019 (COVID-19), Fault conditions, Computational Mechanics, Certification, 01 natural sciences, 010305 fluids & plasmas, law.invention, Mechanical parts, Food and drug administration, Compressed oxygen, Food and Drug Administration, Health care professionals, Industrial partners, Intensive therapy, Ventilation mode, Mechanical ventilator, law, 0103 physical sciences, Pandemic, medicine, 010306 general physics, Fluid Flow and Transfer Processes, Physics, [PHYS]Physics [physics], Mechanical Engineering, healthcare, Articles, Condensed Matter Physics, medicine.disease, 3. Good health, Medical gas supply, Mechanical Ventilation, COVID-19 Pandemic, covid-19, Mechanics of Materials, Others, Ventilation (architecture), Medical emergency, Settore ING-INF/05 - Sistemi di Elaborazione delle Informazioni, [PHYS.ASTR]Physics [physics]/Astrophysics [astro-ph]
Abstract

International audience; This paper presents the Mechanical Ventilator Milano (MVM), a novel intensive therapy mechanical ventilator designed for rapid, large-scale, low-cost production for the COVID-19 pandemic. Free of moving mechanical parts and requiring only a source of compressed oxygen and medical air to operate, the MVM is designed to support the long-term invasive ventilation often required for COVID-19 patients and operates in pressure-regulated ventilation modes, which minimize the risk of furthering lung trauma. The MVM was extensively tested against ISO standards in the laboratory using a breathing simulator, with good agreement between input and measured breathing parameters and performing correctly in response to fault conditions and stability tests. The MVM has obtained Emergency Use Authorization by U.S. Food and Drug Administration (FDA) for use in healthcare settings during the COVID-19 pandemic and Health Canada Medical Device Authorization for Importation or Sale, under Interim Order for Use in Relation to COVID-19. Following these certifications, mass production is ongoing and distribution is under way in several countries. The MVM was designed, tested, prepared for certification, and mass produced in the space of a few months by a unique collaboration of respiratory healthcare professionals and experimental physicists, working with industrial partners, and is an excellent ventilator candidate for this pandemic anywhere in the world

Published
2021

50. Urinary Phosphate and Subclinical Atherosclerosis: The AWHS Study.

Author

Torrijo-Belanche C, Moreno-Franco B, Laclaustra M, Gimeno-Ruiz S, Calvo-Galiano N, Rey-García J, and Guallar-Castillón P

Subjects
Humans, Male, Middle Aged, Cross-Sectional Studies, Risk Factors, Femoral Artery, Plaque, Atherosclerotic urine, Plaque, Atherosclerotic epidemiology, Prevalence, Adult, Coronary Artery Disease urine, Coronary Artery Disease epidemiology, Coronary Artery Disease etiology, Spain epidemiology, Phosphates urine, Atherosclerosis urine, Atherosclerosis epidemiology
Abstract

(1) Background: Atherosclerosis is a leading cause of vascular death worldwide. High urinary phosphate has recently been identified as a cardiovascular risk factor, but its role has not been fully established. The aim of this study was to investigate the association between urinary phosphate and subclinical atherosclerosis in the carotid, femoral as well as coronary territories; (2) Methods: We performed a cross-sectional analysis of a sample of 1169 middle-aged men, aged 50.9 years (SD 3.7), without previous cardiovascular disease, belonging to the Aragon Workers Health Study (AWHS). Urinary phosphate was analyzed in urine samples using the Fiske-Subbarow method. The presence of carotid plaque and femoral plaque was assessed by ultrasound and coronary artery calcium score (CACS) by computed tomography. Demographic, anthropometric and clinical data were collected at annual medical examinations. Logistic regression models were used to estimate the prevalence of adjusted atherosclerosis in the different vascular arteries; (3) Results: A significant inverse association was observed between urinary phosphate and subclinical atherosclerosis in the carotid [OR 95% CI 0.69 (0.49-0.99)] and coronary (CACS > 200) [OR 95% CI 0.46 (0.23-0.88)] arteries; however, no statistically significant association was found between urinary phosphate and the presence of atheroma plaques in the femoral territory [OR 1.02 (0.72-1.45)]; (4) Conclusions: In middle-aged men, a higher urinary phosphate concentration is associated with a lower prevalence of subclinical carotid and coronary atherosclerosis compared with those with a lower urinary phosphate concentration.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results